- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Presidential Campaigns and the Cost of Medicine
What we're reading on October 13, 2015: presidential hopeful Marco Rubio taps health policy expert Avik Roy to advise his campaign, Democrats will tangle over healthcare in first debate, and the US pays 3 times as much for medicine as Britain.
Avik Roy Signs Up With Marco Rubio’s Camp
The senior fellow at the Manhattan Institute and top conservative health policy expert has signed on as an advisor for Senator Marco Rubio’s (R-FL) presidential campaign, reported The Hill. Roy was advising Texas Governor Rick Perry before he dropped out of the race, and in 2012, Roy advised Mitt Romney’s campaign.
Read more: http://bit.ly/1R8Zo3T
In early 2015, Roy discussed with The American Journal of Managed Care his expectations for the 2016 presidential election and promises to repeal and replace President Obama’s Affordable Care Act (ACA). Roy has introduced his own approach for fixing the health law.
Democrats to Tangle Over Healthcare?
The Democratic presidential candidates will hold their first primary debate and healthcare is expected to be a point of discussion. Modern Healthcare outlines the stances of the 3 top candidates—Hillary Clinton, Senator Bernie Sanders (I-VT), and Maryland Governor Martin O’Malley—on the Cadillac tax, slowing prescription drug prices, and the ACA in general in advance of the debate tonight.
Read more: http://bit.ly/1R909tv
America Pays 3 Times More for Medicine Than Britain
Researchers at Britain’s University of Liverpool found US prices for the world’s 20 top-selling drugs are 3 times higher than in Britain. In general, US prices were consistently higher than other European markets. The difference, according to Reuters, is that the US leaves pricing to market competition and other countries where governments directly or indirectly control costs have much lower prices.
Read more: http://reut.rs/1NBLl98
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
